Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Sergio García‐Fernández"'
Autor:
Concha Ortiz-Cartagena, Daniel Pablo-Marcos, Laura Fernández-García, Lucía Blasco, Olga Pacios, Inés Bleriot, María Siller, María López, Javier Fernández, Belén Aracil, Pablo Arturo Fraile-Ribot, Sergio García-Fernández, Felipe Fernández-Cuenca, Marta Hernández-García, Rafael Cantón, Jorge Calvo-Montes, María Tomás
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Carbapenem-resistant pathogens have been recognized as a health concern as they are both difficult to treat and detect in clinical microbiology laboratories. Researchers are making great efforts to develop highly specific, sensitive, accurat
Externí odkaz:
https://doaj.org/article/84bc09a95f104ef695408a888a0ea7d7
Autor:
Sergio García-Fernández, Jorge Calvo, Emilia Cercenado, Ana Isabel Suárez-Barrenechea, María Fernández-Billón, Francisco Javier Castillo, Lydia Gálvez-Benítez, Fe Tubau, Ruth Esther Figueroa Cerón, Alicia Hernández-Cabezas, Fernando González Romo, María Carmen Fariñas, María Gómez, Jazmín Díaz-Regañón, Rafael Cantón
Publikováno v:
Revista Española de Quimioterapia. 36:302-309
Objectives. To determine susceptibility to the novel β-lactam/β-lactamase inhibitor combination imipenem/relebactam in clinical isolates recovered from intra-abdominal (IAI), urinary (UTI), respiratory (RTI) and bloodstream (BSI) infections in the
Autor:
Marta Hernández-García, María García-Castillo, Sergio García-Fernández, Diego López-Mendoza, Jazmín Díaz-Regañón, João Romano, Leonor Pássaro, Laura Paixão, Rafael Cantón
Publikováno v:
Microorganisms, Vol 9, Iss 2, p 388 (2021)
CrpP enzymes have been recently described as a novel ciprofloxacin-resistance mechanism. We investigated by whole genome sequencing the presence of crpP-genes and other mechanisms involved in quinolone resistance in MDR/XDR-Pseudomonas aeruginosa iso
Externí odkaz:
https://doaj.org/article/1f92728f020c4fe482b757ea859f155a
Autor:
Rosa Escudero-Sánchez, María Ruiz-Ruigómez, Jorge Fernández-Fradejas, Sergio García Fernández, María Olmedo Samperio, Angela Cano Yuste, Angela Valencia Alijo, Beatriz Díaz-Pollán, María Jesús Rodríguez Hernández, Esperanza Merino De Lucas, Oriol Martín Segarra, Carmen Sáez Bejar, Carlos Armiñanzas Castillo, Belén Gutiérrez-Gutiérrez, Dolors Rodríguez-Pardo, Antonio Ramos-Martínez, Julián Torre-Cisneros, Francisco López-Medrano, Javier Cobo Reinoso
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1, p 2 (2020)
Bezlotoxumab is marketed for the prevention of recurrent Clostridioides difficile infection (rCDI). Its high cost could be determining its prescription to a different population than that represented in clinical trials. The objective of the study was
Externí odkaz:
https://doaj.org/article/bce9a04340354d138bb487d0488f0b56
Autor:
Inês Alencastre, Uday S. Annapure, Ricardo Araujo, Raquel D.N. Arifa, Clara Lara Aroco, Sampan Attri, Maria Azevedo, Aaditi Bagul, Saurabh Bansal, Rafaela R.A. Batista, Ana Moreno Blanco, Camila B. Brito, Eun-Ha Choi, Miran Čoklo, Carolina F.F.A. Costa, Nabendu Debnath, Rosa del Campo Moreno, Sunmathi Dhandapani, Ivan Dolanc, Caio Tavares Fagundes, Micheli Fagundes, Sergio García-Fernández, Gunjan Goel, Juan Miguel Rodríguez Gómez, Ihn Han, Antonija Jonjić, Arti Kataria, Mudassir Azeez Khan, Sandra Kraljević Pavelić, Ashwani Kumar, Manoj Kumar, M. Carmen Martínez-Cuesta, Pawan Kumar Maurya, Ana Merino-Ribas, Ravinder Nagpal, Pratisha Nair, Carmen Peláez, Manuel Pestana, Manuel Ponce-Alonso, Teresa Requena, Concepción Rodríguez-Jiménez, Vikas Saini, Benedita Sampaio-Maia, Oluwatoyin Sangokunle, Ayushi Sharma, Rahul Shrivastava, Prashant Singh, B.M. Snehalatha, Beatriz Solo de Zaldívar, Daniele G. Souza, Ankit Srivastava, Anamika Verma, Ashok Kumar Yadav, Dharmendra Kumar Yadav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb6fad12834085065d6ad29ba8c8121d
https://doi.org/10.1016/b978-0-323-91313-3.09995-5
https://doi.org/10.1016/b978-0-323-91313-3.09995-5
Fecal microbiota transfer: Basic and clinical aspects, current applications, and future perspectives
Autor:
Manuel Ponce-Alonso, Sergio García-Fernández, Ana Moreno Blanco, Clara Lara Aroco, Concepción Rodríguez-Jiménez, Rosa del Campo Moreno
20 p.-2 fig.-2 tab.
This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (PI20/00164) and co-funded by the European Regional Development Fund (ERDF) and the Spanish Network for Research in
This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (PI20/00164) and co-funded by the European Regional Development Fund (ERDF) and the Spanish Network for Research in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b53d315ff3eafbcf9bb89ad4f8ebce
http://hdl.handle.net/10261/330783
http://hdl.handle.net/10261/330783
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 39:165-167
Autor:
Sergio García-Fernández, Laura Martínez-García, Manuel Ponce-Alonso, Rosario Pintor, Javier Sáez de la Fuente, Rosa Escudero-Sánchez, Paloma Moreno-Nunez, Angela Rincón-Carlavilla, Javier Cobo
Publikováno v:
Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
Infection Control & Hospital Epidemiology
Objectives:The coronavirus disease 2019 (COVID-19) pandemic has induced a reinforcement of infection control measures in the hospital setting. Here, we assess the impact of the COVID-19 pandemic on the incidence of nosocomial Clostridioides difficile
Autor:
Sergio García-Fernández, Mercedes de la Cruz, Tanja Schneider, Olga Genilloud, Jesús Martín, Anna Müller, Fernando Reyes, Marina Sánchez-Hidalgo, Julia Patricia Deisinger, Francisco Javier Ortiz-López, Daniel Carretero-Molina, Ignacio González, Fernando Román-Hurtado
Publikováno v:
Angewandte Chemie International Edition. 59:12654-12658
Lantibiotics are ribosomally synthesized and post-translationally modified peptides (RiPPs) characterized by the presence of lanthionine or methyllanthionine rings and their antimicrobial activity. Cacaoidin, a novel glycosylated lantibiotic, was iso
Autor:
Rosa Escudero-Sanchez, Alfonso Muriel García, Sergio García Fernández, Angela Valencia Alijo, Mariona Tasias Pitarch, Esperanza Merino De Lucas, Angela Gutierrez Rojas, Antonio Ramos Martínez, Miguel Salavert Lletí, Livia Giner, María Ruíz Ruigomez, Lorena García Basas, Jorge Fernández Fradejas, María Olmedo Sampedrio, Angela Cano Yuste, Beatriz Díaz Pollán, María Jesús Rodríguez Hernández, Oriol Martín Segarra, Carmen Sáez Bejar, Carlos Armiñanzas Castillo, Belén Gutiérrez, Dolors Rodríguez-Pardo, Julián De La Torre Cisneros, Francisco López Medrano, Javier Cobo Reinoso
Publikováno v:
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Background Both fidaxomicin and bezlotoxumab (used in combination with an antibiotic against Clostridioides difficile) achieve reductions in recurrence rates of C. difficile infection (CDI). However, the two strategies have never been compared. Metho